Sartorius Stedim Biotech Stock Market Value

SDMHF Stock  USD 209.00  0.06  0.03%   
Sartorius Stedim's market value is the price at which a share of Sartorius Stedim trades on a public exchange. It measures the collective expectations of Sartorius Stedim Biotech investors about its performance. Sartorius Stedim is trading at 209.00 as of the 25th of March 2025. This is a 0.03% down since the beginning of the trading day. The stock's lowest day price was 209.0.
With this module, you can estimate the performance of a buy and hold strategy of Sartorius Stedim Biotech and determine expected loss or profit from investing in Sartorius Stedim over a given investment horizon. Check out Sartorius Stedim Correlation, Sartorius Stedim Volatility and Sartorius Stedim Alpha and Beta module to complement your research on Sartorius Stedim.
Symbol

Please note, there is a significant difference between Sartorius Stedim's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sartorius Stedim is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sartorius Stedim's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Sartorius Stedim 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sartorius Stedim's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sartorius Stedim.
0.00
12/25/2024
No Change 0.00  0.0 
In 2 months and 31 days
03/25/2025
0.00
If you would invest  0.00  in Sartorius Stedim on December 25, 2024 and sell it all today you would earn a total of 0.00 from holding Sartorius Stedim Biotech or generate 0.0% return on investment in Sartorius Stedim over 90 days. Sartorius Stedim is related to or competes with Repligen, Cooper Companies,, Teleflex Incorporated, ResMed, Becton Dickinson, Hologic, and STAAR Surgical. Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwid... More

Sartorius Stedim Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sartorius Stedim's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sartorius Stedim Biotech upside and downside potential and time the market with a certain degree of confidence.

Sartorius Stedim Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Sartorius Stedim's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sartorius Stedim's standard deviation. In reality, there are many statistical measures that can use Sartorius Stedim historical prices to predict the future Sartorius Stedim's volatility.
Hype
Prediction
LowEstimatedHigh
206.49209.00211.51
Details
Intrinsic
Valuation
LowRealHigh
179.32181.83229.90
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Sartorius Stedim. Your research has to be compared to or analyzed against Sartorius Stedim's peers to derive any actionable benefits. When done correctly, Sartorius Stedim's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Sartorius Stedim Biotech.

Sartorius Stedim Biotech Backtested Returns

At this point, Sartorius Stedim is very steady. Sartorius Stedim Biotech owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0588, which indicates the firm had a 0.0588 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Sartorius Stedim Biotech, which you can use to evaluate the volatility of the company. Please validate Sartorius Stedim's Risk Adjusted Performance of 0.059, semi deviation of 1.64, and Coefficient Of Variation of 1715.03 to confirm if the risk estimate we provide is consistent with the expected return of 0.15%. Sartorius Stedim has a performance score of 4 on a scale of 0 to 100. The entity has a beta of 0.32, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Sartorius Stedim's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sartorius Stedim is expected to be smaller as well. Sartorius Stedim Biotech right now has a risk of 2.53%. Please validate Sartorius Stedim expected short fall, and the relationship between the value at risk and rate of daily change , to decide if Sartorius Stedim will be following its existing price patterns.

Auto-correlation

    
  -0.19  

Insignificant reverse predictability

Sartorius Stedim Biotech has insignificant reverse predictability. Overlapping area represents the amount of predictability between Sartorius Stedim time series from 25th of December 2024 to 8th of February 2025 and 8th of February 2025 to 25th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sartorius Stedim Biotech price movement. The serial correlation of -0.19 indicates that over 19.0% of current Sartorius Stedim price fluctuation can be explain by its past prices.
Correlation Coefficient-0.19
Spearman Rank Test-0.47
Residual Average0.0
Price Variance64.53
Sartorius ReturnsSartorius Lagged ReturnsDiversified AwaySartorius ReturnsSartorius Lagged ReturnsDiversified Away100%

Sartorius Stedim Biotech lagged returns against current returns

Autocorrelation, which is Sartorius Stedim pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sartorius Stedim's pink sheet expected returns. We can calculate the autocorrelation of Sartorius Stedim returns to help us make a trade decision. For example, suppose you find that Sartorius Stedim has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
JavaScript chart by amCharts 3.21.15Feb 10Feb 15Feb 20Feb 25MarMar 07Mar 12Mar 17Mar 22-5%0%5%10%15%20%
JavaScript chart by amCharts 3.21.15Volume Lagged Volume Prices Lagged Prices
       Timeline  

Sartorius Stedim regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sartorius Stedim pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sartorius Stedim pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sartorius Stedim pink sheet over time.
   Current vs Lagged Prices   
JavaScript chart by amCharts 3.21.15Feb 10Feb 15Feb 20Feb 25MarMar 07Mar 12Mar 17Mar 22190195200205210215220225230
JavaScript chart by amCharts 3.21.15Regression Prices Lagged Regression Prices
       Timeline  

Sartorius Stedim Lagged Returns

When evaluating Sartorius Stedim's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sartorius Stedim pink sheet have on its future price. Sartorius Stedim autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sartorius Stedim autocorrelation shows the relationship between Sartorius Stedim pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Sartorius Stedim Biotech.
   Regressed Prices   
JavaScript chart by amCharts 3.21.152025FebMar195200205210215220225230235
JavaScript chart by amCharts 3.21.15Lagged Returns Returns
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Sartorius Pink Sheet

Sartorius Stedim financial ratios help investors to determine whether Sartorius Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sartorius with respect to the benefits of owning Sartorius Stedim security.
News Freq…Investor S…